Brief: Pentixapharm Sets Price Range For Planned IPO
Sept 23 (Reuters) - Eckert & Ziegler SE EUZG.DE :
* PENTIXAPHARM HOLDING AG SETS PRICE RANGE FOR PLANNED IPO
* PENTIXAPHARM- OFFERING OF UP TO 3.9 MILLION NEW SHARES AT
A
PRICE RANGE OF EUR 4.70 TO EUR 6.00 PER SHARE
* PENTIXAPHARM: SUBSCRIPTION PERIOD FOR INSTITUTIONAL AND
RETAIL
INVESTORS BEGINS ON SEPTEMBER 24, 2024, AND IS EXPECTED TO END
ON OCTOBER 1, 2024
Source text for Eikon: ID:
Further company coverage: EUZG.DE
((frankfurt.newsroom@thomsonreuters.com;))
Recent news on Eckert & Ziegler SE
See all newsBrief: Eckert & Ziegler Brazil And Terthera Sign Supply Agreement For Terbium-161
Germany's Eckert & Ziegler H1 net income rises, confirms FY view
Brief: Eckert & Ziegler - FY Outlook Confirmed
Brief: Eckert & Ziegler: BaFin Questions Pentixapharm Spin-Off Accounting at Eckert & Ziegler
Germany's Eckert & Ziegler Q1 sales rise on medical segment growth